Advertisement

Topics

Arcturus Reinstates Fired CEO After Regime Change in Boardroom

18:48 EDT 31 May 2018 | Xconomy

The San Diego RNA drug developer Arcturus Therapeutics (NASDAQ: ARCT) on Thursday reinstated fired CEO Joseph Payne and named ResMed (NYSE: RMD) founder Peter Farrell as chairman of the company’s new board of directors. The four members of the company’s previous board, who resigned as part of an agreement reached last weekend, fired Payne in […]

Original Article: Arcturus Reinstates Fired CEO After Regime Change in Boardroom

NEXT ARTICLE

More From BioPortfolio on "Arcturus Reinstates Fired CEO After Regime Change in Boardroom"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...